Tirdzniecība GoodRx Holdings, Inc. - GDRX CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.05 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.030779% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.013666% | ||||||||
Nakts laika nodeva | 22:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | USD | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | United States of America | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Iepriekš. aizvērt* | 5.61 |
Atvērt* | 5.45 |
Izmaiņas par 1 gadu* | -80.57% |
Dienas Diapazons* | 5.45 - 5.65 |
52 ned Diapazons | 3.82-30.89 |
Vidējais apjoms (10 dienas) | 2.22M |
Vidējais apjoms (3 mēneši) | 38.79M |
Tirgus Kapitalizācija | 2.24B |
Cenas/Peļņas Attiecība | -100.00K |
Izvietotās Akcijas | 709.92M |
Ieņēmumi | 795.70M |
EPS | -0.17 |
Dividende (Ienesīgums %) | N/A |
Beta | -100.00K |
Nākamās Peļņas Datums | Feb 28, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
Feb 8, 2023 | 5.46 | -0.05 | -0.91% | 5.51 | 5.65 | 5.42 |
Feb 7, 2023 | 5.61 | 0.30 | 5.65% | 5.31 | 5.65 | 5.31 |
Feb 6, 2023 | 5.38 | -0.23 | -4.10% | 5.61 | 5.67 | 5.32 |
Feb 3, 2023 | 5.74 | -0.15 | -2.55% | 5.89 | 6.08 | 5.67 |
Feb 2, 2023 | 6.10 | 0.13 | 2.18% | 5.97 | 6.22 | 5.88 |
Feb 1, 2023 | 5.88 | 0.35 | 6.33% | 5.53 | 5.89 | 5.43 |
Jan 31, 2023 | 5.55 | 0.34 | 6.53% | 5.21 | 5.59 | 5.14 |
Jan 30, 2023 | 5.28 | 0.19 | 3.73% | 5.09 | 5.49 | 5.09 |
Jan 27, 2023 | 5.28 | 0.39 | 7.98% | 4.89 | 5.36 | 4.85 |
Jan 26, 2023 | 4.96 | 0.09 | 1.85% | 4.87 | 4.99 | 4.78 |
Jan 25, 2023 | 4.79 | -0.19 | -3.82% | 4.98 | 5.04 | 4.65 |
Jan 24, 2023 | 5.16 | -0.31 | -5.67% | 5.47 | 5.60 | 5.14 |
Jan 23, 2023 | 5.60 | 0.43 | 8.32% | 5.17 | 5.68 | 5.17 |
Jan 20, 2023 | 5.27 | 0.06 | 1.15% | 5.21 | 5.32 | 5.08 |
Jan 19, 2023 | 5.15 | 0.21 | 4.25% | 4.94 | 5.19 | 4.91 |
Jan 18, 2023 | 5.18 | -0.13 | -2.45% | 5.31 | 5.47 | 5.18 |
Jan 17, 2023 | 5.33 | 0.19 | 3.70% | 5.14 | 5.45 | 5.03 |
Jan 13, 2023 | 5.25 | 0.18 | 3.55% | 5.07 | 5.26 | 4.93 |
Jan 12, 2023 | 5.17 | 0.00 | 0.00% | 5.17 | 5.21 | 5.02 |
Jan 11, 2023 | 5.16 | 0.06 | 1.18% | 5.10 | 5.22 | 5.01 |
GoodRx Holdings, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Kopējie ienākumi | 99.377 | 157.24 | 249.522 | 388.224 | 550.7 | 745.424 |
Ienākumi | 99.377 | 157.24 | 249.522 | 388.224 | 550.7 | 745.424 |
Cost of Revenue, Total | 1.23 | 3.075 | 6.035 | 14.016 | 29.587 | 46.716 |
Bruto Peļņa | 98.147 | 154.165 | 243.487 | 374.208 | 521.113 | 698.708 |
Kopējie Darbības Izdevumi | 80.602 | 110.596 | 175.128 | 253.425 | 826.419 | 732.018 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 64.541 | 83.26 | 112.536 | 191.659 | 715.586 | 524.903 |
Pētniecība un Attīstība | 5.742 | 11.501 | 43.894 | 29.3 | 61.816 | 125.86 |
Depreciation / Amortization | 9.089 | 9.099 | 9.806 | 13.573 | 18.43 | 34.539 |
Darbības Izdevumi | 18.775 | 46.644 | 74.394 | 134.799 | -275.719 | 13.406 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -3.52 | -6.946 | -22.039 | -48.854 | -27.753 | -23.583 |
Citi, Neto | -0.154 | 0.005 | -0.007 | -2.967 | 0.022 | 0 |
Neto Ienākumi Pirms Nodokļu Nomaksas | 15.101 | 39.703 | 52.348 | 82.978 | -303.45 | -10.177 |
Neto Ienākumi Pēc Nodokļu Nomaksas | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Neto Ienākumi | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Atšķaidītie Neto Ienākumi | 8.913 | 28.772 | 43.793 | 66.048 | -293.623 | -25.254 |
Atšķaidītie Ienākumi par Akcijām | 383.223 | 383.223 | 383.223 | 383.223 | 274.696 | 409.981 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.02326 | 0.07508 | 0.11428 | 0.17235 | -1.0689 | -0.0616 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | 0.02326 | 0.082 | 0.12051 | 0.18248 | -1.06654 | -0.03893 |
Neparedzēti Izdevumi (Ienākumi) | 3.661 | 2.857 | 4.877 | 1 | 0 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Kopējie ienākumi | 160.431 | 176.635 | 195.102 | 213.256 | 203.329 |
Ienākumi | 160.431 | 176.635 | 195.102 | 213.256 | 203.329 |
Cost of Revenue, Total | 10.428 | 11.09 | 11.271 | 13.927 | 12.28 |
Bruto Peļņa | 150.003 | 165.545 | 183.831 | 199.329 | 191.049 |
Kopējie Darbības Izdevumi | 165.429 | 176.986 | 188.103 | 201.5 | 183.568 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 123.48 | 127.96 | 131.598 | 141.865 | 124.873 |
Pētniecība un Attīstība | 26.16 | 29.567 | 35.073 | 35.06 | 35.042 |
Depreciation / Amortization | 5.361 | 8.369 | 10.161 | 10.648 | 11.373 |
Darbības Izdevumi | -4.998 | -0.351 | 6.999 | 11.756 | 19.761 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -5.889 | -5.893 | -5.915 | -5.886 | -5.817 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -10.887 | -6.244 | 1.084 | 5.87 | 13.944 |
Neto Ienākumi Pēc Nodokļu Nomaksas | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Neto Ienākumi | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 1.668 | 31.061 | -18.069 | -39.914 | 12.293 |
Atšķaidītie Neto Ienākumi | 1.668 | 31.061 | -18.069 | -39.914 | 12.8213 |
Atšķaidītie Ienākumi par Akcijām | 429.577 | 428.867 | 411.223 | 414.068 | 427.378 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.00388 | 0.07243 | -0.04394 | -0.09639 | 0.03 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | 0.00849 | 0.07819 | -0.0402 | -0.08841 | 0.03471 |
Citi, Neto | 0 | 0 | 0 | ||
Neparedzēti Izdevumi (Ienākumi) | 0 | ||||
Atšķaidīšanas Iestāstīšana | 0.52834 |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 73.071 | 86.582 | 1086.37 | 1088.83 | ||
Nauda un Īstermiņa Ieguldījumi | 34.6 | 26.05 | 968.691 | 941.109 | ||
Cash | 34.6 | 26.05 | 968.691 | 941.109 | ||
Debitoru Parādu Kopsumma, Neto | 35.023 | 48.129 | 97.293 | 126.411 | ||
Accounts Receivable - Trade, Net | 33.359 | 48.129 | 68.729 | 118.08 | ||
Prepaid Expenses | 3.448 | 12.403 | 17.484 | 21.307 | ||
Total Assets | 314.791 | 386.796 | 1470.11 | 1607.62 | ||
Property/Plant/Equipment, Total - Net | 0.988 | 34.175 | 50.769 | 49.317 | ||
Property/Plant/Equipment, Total - Gross | 1.542 | 35.442 | 52.899 | 55.146 | ||
Accumulated Depreciation, Total | -0.554 | -1.267 | -2.13 | -5.829 | ||
Goodwill, Net | 220.42 | 236.225 | 261.116 | 329.696 | ||
Intangibles, Net | 18.27 | 26.445 | 56.719 | 133.778 | ||
Other Long Term Assets, Total | 2.042 | 3.369 | 15.142 | 6.007 | ||
Total Current Liabilities | 16.62 | 33.373 | 59.551 | 81.113 | ||
Accounts Payable | 7.2 | 7.851 | 10.291 | 17.501 | ||
Accrued Expenses | 3.732 | 13.691 | 35.379 | 49.714 | ||
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | ||
Current Port. of LT Debt/Capital Leases | 5.43 | 7.029 | 7.029 | 7.029 | ||
Other Current Liabilities, Total | 0.258 | 4.802 | 6.852 | 6.869 | ||
Total Liabilities | 740.209 | 737.369 | 758.755 | 775.945 | ||
Total Long Term Debt | 716.806 | 663.893 | 659.888 | 655.858 | ||
Long Term Debt | 716.806 | 663.893 | 659.888 | 655.858 | ||
Deferred Income Tax | 3.456 | 0.244 | ||||
Other Liabilities, Total | 3.327 | 40.103 | 39.316 | 38.73 | ||
Total Equity | -425.418 | -350.573 | 711.359 | 831.68 | ||
Redeemable Preferred Stock | 737.009 | 737.009 | 0 | 0 | ||
Common Stock | 0.451 | 0.46 | 0.039 | 0.04 | ||
Retained Earnings (Accumulated Deficit) | -1162.88 | -1096.83 | -1390.45 | -1415.71 | ||
Total Liabilities & Shareholders’ Equity | 314.791 | 386.796 | 1470.11 | 1607.62 | ||
Total Common Shares Outstanding | 383.223 | 383.223 | 391.66 | 398.681 | ||
Additional Paid-In Capital | 8.788 | 2101.77 | 2247.35 | |||
Other Current Assets, Total | 2.9 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 1123.38 | 1075.75 | 1051.54 | 1088.83 | 994.723 |
Nauda un Īstermiņa Ieguldījumi | 990.463 | 894.703 | 912.023 | 941.109 | 845.427 |
Cash | 990.463 | 894.703 | 912.023 | 941.109 | 845.427 |
Debitoru Parādu Kopsumma, Neto | 115.791 | 166.801 | 126.38 | 126.411 | 129.107 |
Accounts Receivable - Trade, Net | 74.399 | 87.004 | 98.511 | 118.08 | 123.281 |
Prepaid Expenses | 14.226 | 14.246 | 13.137 | 21.307 | 20.189 |
Other Current Assets, Total | 2.9 | 0 | 0 | 0 | |
Total Assets | 1510.97 | 1586.93 | 1614.36 | 1607.62 | 1538.33 |
Property/Plant/Equipment, Total - Net | 50.576 | 49.007 | 47.806 | 49.317 | 49.542 |
Goodwill, Net | 261.116 | 320.196 | 329.696 | 329.696 | 334.642 |
Intangibles, Net | 60.387 | 126.776 | 133.331 | 133.778 | 138.495 |
Other Long Term Assets, Total | 15.515 | 15.2 | 51.992 | 6.007 | 20.926 |
Total Current Liabilities | 63.049 | 65.491 | 72.681 | 81.113 | 59.364 |
Accounts Payable | 15.101 | 18.378 | 17.279 | 17.501 | 12.82 |
Accrued Expenses | 32.115 | 31.185 | 40.163 | 49.714 | 29.196 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.029 | 7.029 | 7.029 | 7.029 | 7.029 |
Other Current Liabilities, Total | 8.804 | 8.899 | 8.21 | 6.869 | 10.319 |
Total Liabilities | 761.915 | 762.535 | 767.969 | 775.945 | 751.821 |
Total Long Term Debt | 658.883 | 657.877 | 656.868 | 655.858 | 654.845 |
Long Term Debt | 658.883 | 657.877 | 656.868 | 655.858 | 654.845 |
Other Liabilities, Total | 39.983 | 39.167 | 38.42 | 38.73 | 37.215 |
Total Equity | 749.059 | 824.394 | 846.396 | 831.68 | 786.507 |
Common Stock | 0.039 | 0.039 | 0.039 | 0.04 | 0.04 |
Additional Paid-In Capital | 2137.8 | 2182.08 | 2222.15 | 2247.35 | 2189.88 |
Retained Earnings (Accumulated Deficit) | -1388.79 | -1357.72 | -1375.79 | -1415.71 | -1403.41 |
Total Liabilities & Shareholders’ Equity | 1510.97 | 1586.93 | 1614.36 | 1607.62 | 1538.33 |
Total Common Shares Outstanding | 392.457 | 395.393 | 398.681 | 398.681 | 396.132 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Deferred Income Tax | 0.244 | 0.397 |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | 43.793 | 66.048 | -293.623 | -25.254 | ||
Nauda no Darbības | 45.253 | 83.286 | 131.341 | 178.779 | ||
Nauda no Darbības | 9.806 | 13.573 | 18.43 | 34.539 | ||
Deferred Taxes | -2.433 | -5.674 | -10.91 | 12.851 | ||
Bezskaidras Naudas Preces | 5.858 | 14.155 | 449.903 | 168.439 | ||
Cash Taxes Paid | 11.7 | 19.4 | 29.228 | 18.105 | ||
Samaksātie Procenti Naudā | 18.658 | 48.443 | 24.517 | 20.198 | ||
Izmaiņas Apgrozāmajā Kapitālā | -11.771 | -4.816 | -32.459 | -11.796 | ||
Nauda no Ieguldījumu Darbībām | -3.458 | -37.055 | -91.617 | -178.733 | ||
Kapitālie Izdevumi | -3.458 | -5.749 | -35.824 | -34.457 | ||
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | 0 | -31.306 | -55.793 | -144.276 | ||
Nauda no Darbībām ar Finansēšanu | -24.734 | -54.781 | 905.817 | -30.528 | ||
Naudas Plūsma Finansēšanas Posteņos | -1371.97 | -2.214 | 15.043 | -58.52 | ||
Akciju Izsniegšana (Atkāpšanās), Neto | 740.358 | 4.665 | 897.803 | 35.021 | ||
Parādu Izsniegšana (Atkāpšanās), Neto | 606.876 | -57.232 | -7.029 | -7.029 | ||
Neto Izmaiņas Naudā | 17.061 | -8.55 | 945.541 | -30.482 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 1.668 | 32.729 | 14.66 | -25.254 | 12.293 |
Cash From Operating Activities | 45.485 | 80.411 | 128.969 | 178.779 | 30.12 |
Cash From Operating Activities | 5.361 | 13.73 | 23.891 | 34.539 | 11.373 |
Deferred Taxes | -0.227 | -0.364 | -33.217 | 12.851 | -0.394 |
Non-Cash Items | 48.261 | 91.5 | 133.649 | 168.439 | 31.732 |
Changes in Working Capital | -9.578 | -57.184 | -10.014 | -11.796 | -24.884 |
Cash From Investing Activities | -9.695 | -142.416 | -169.474 | -178.733 | -34.401 |
Capital Expenditures | -9.695 | -16.688 | -25.198 | -34.457 | -12.418 |
Cash From Financing Activities | -14.018 | -14.883 | -19.063 | -30.528 | -91.401 |
Financing Cash Flow Items | -14.633 | -26.849 | -43.506 | -58.52 | -9.561 |
Issuance (Retirement) of Stock, Net | 2.372 | 15.481 | 29.715 | 35.021 | -80.082 |
Issuance (Retirement) of Debt, Net | -1.757 | -3.515 | -5.272 | -7.029 | -1.758 |
Net Change in Cash | 21.772 | -76.888 | -59.568 | -30.482 | -95.682 |
Other Investing Cash Flow Items, Total | -125.728 | -144.276 | -144.276 | -21.983 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.4792 | 7816360 | 739017 | 2022-09-30 | LOW |
Millennium Management LLC | Hedge Fund | 5.3318 | 4396531 | 2279989 | 2022-12-13 | HIGH |
Light Street Capital Management, LLC | Investment Advisor/Hedge Fund | 5.0836 | 4191872 | -437404 | 2022-09-30 | HIGH |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 4.3934 | 3622709 | 55218 | 2022-09-30 | HIGH |
Silver Lake Partners | Private Equity | 4.2837 | 3532276 | 0 | 2022-09-30 | LOW |
Slutsky (Andrew) | Individual Investor | 3.887 | 3205126 | 31512 | 2022-04-19 | LOW |
Two Sigma Investments, LP | Hedge Fund | 3.6134 | 2979556 | -63560 | 2022-09-30 | HIGH |
Renaissance Technologies LLC | Hedge Fund | 2.6942 | 2221622 | -1024000 | 2022-09-30 | HIGH |
Perot Investments | Investment Advisor/Hedge Fund | 2.6238 | 2163566 | 359632 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.0657 | 1703329 | 234672 | 2022-09-30 | LOW |
Technology Crossover Ventures | Venture Capital | 2.0053 | 1653566 | 0 | 2022-09-30 | LOW |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 1.8559 | 1530333 | 1530333 | 2022-09-30 | MED |
Voloridge Investment Management, LLC | Investment Advisor/Hedge Fund | 1.4858 | 1225186 | 806904 | 2022-09-30 | HIGH |
Norwood Investment Partners, LP | Investment Advisor | 1.4808 | 1221000 | 1194742 | 2022-09-30 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 1.385 | 1142009 | 594803 | 2022-09-30 | MED |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.1537 | 951343 | -137008 | 2022-09-30 | HIGH |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.9515 | 784568 | 260599 | 2022-09-30 | LOW |
Manulife Investment Management (North America) Limited | Investment Advisor | 0.8914 | 735028 | 352110 | 2022-09-30 | LOW |
Goldman Sachs & Company, Inc. | Research Firm | 0.8566 | 706359 | 254727 | 2022-09-30 | MED |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8553 | 705300 | 705300 | 2021-12-31 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com GroupTirgotāji
Ikmēneša aktīvie klienti
Ikmēneša ieguldījumu apjoms
Izņemts katru mēnesi
Treidinga kalkulators
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
GoodRx Holdings, Inc. Company profile
Par GoodRx Holdings, Inc.
GoodRx Holdings, Inc. ir uz patērētāju orientēta digitālās veselības aprūpes platforma. Uzņēmums nodrošina GoodRx platformu, kas apkopo un analizē cenu datus no dažādiem avotiem. Platforma nodrošina piekļuvi medikamentu ietaupījumu programmām, medicīnas pakalpojumu sniedzēju konsultācijām un laboratoriskajiem izmeklējumiem, izmantojot savus televeselības piedāvājumus GoodRx Care un GoodRx Telehealth Marketplace, kā arī citu ar veselības aprūpi saistītu saturu. Tās recepšu piedāvājums nodrošina recepšu cenu salīdzināšanu un sarunu procedūras par recepšu cenām. Abonēšanas piedāvājums nodrošina patērētājiem un viņu ģimenēm piekļuvi zemākām recepšu cenām izvēlētiem medikamentiem izvēlētās aptiekās par mēneša vai gada abonēšanas maksu. Tās farmācijas ražotāji piedāvā tādus pieejamus risinājumus, piemēram, līdzmaksājumu kartes, pacientu palīdzības programmas, aprūpes portālus un citas ietaupījumu iespējas. Tās recepšu darījumu piedāvājums nodrošina atlasītus, ģeogrāfiski atbilstošus cenu salīdzinājumus un recepšu cenas, par kurām panākta vienošanās.
Industry: | Online Services (NEC) |
2701 Olympic Boulevard
Suite 990
SANTA MONICA
CALIFORNIA 90404
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com